MARKETWIRE.NET

Decode Your Next Market Move

Global Industry Analysts, Inc. (GIA) launches comprehensive analysis of industry segments, market trends, growth drivers, market share, size and demand forecasts on the global Radiation Therapy Equipment market. Market segmentation includes Type (External Beam Radiation Therapy, Internal Radiation Therapy, Systemic Radiation Therapy); End-Use (Hospitals, Other End-Uses).

Find Out More About Regions, Brands, Dominant, Active & Niche Companies Covered in the Report

24 November 2:26 a.m., Silicon Valley, California - According to the new market research report, the global market for Radiation Therapy Equipment is projected to grow at a CAGR of 4.2% reach US$6.9 Billion by 2027, driven by the constant increase in the number of cancer patients across the world and the increasing adoption of radiation therapy for treatment of cancer. The global Radiation Therapy Equipment market will be reset to a new normal which going forwards in a post COVID-19 era will be continuously redefined and redesigned. External Beam Radiation Therapy, one of the segments analyzed and sized in this study, is forecast to grow at over 4.4% and reach a market size of US$5.9 billion by the end of the analysis period. The United States is forecast to readjust to a 3.7% CAGR. Within Europe, the worst affected by the pandemic, Germany will reach a market size of US$412 million growing at a CAGR of 4.1% over the next couple of years. In addition, over US$66 million worth of projected demand in the region will come from Rest of European markets. In Japan, the External Beam Radiation Therapy segment will reach a market size of US$375 million by the close of the analysis period. Facing a global backlash over the coronavirus outbreak and spread, China the world's second largest economy faces economic and geopolitical challenges including economic distancing which can likely put China's monopoly of global supply chains in crisis. The External Beam Radiation Therapy segment in this country against this backdrop will grow at a CAGR of 6% over the next couple of years to create an addressable market opportunity worth US$492 million by the year 2027.

Radiation therapy or radiotherapy has emerged as an integral part of treatment for cancer patients. By using high-energy radiation from sources such as X-rays, neutrons, protons, and gamma rays, radiotherapy kills cancer-affected tissues or prevents multiplication of cancer cells in the body. The therapy is also used for shrinking tumor cells, and for addressing symptoms of cancer such as reducing pain and pressure. Radiation therapy finds use in the treatment of various types of cancer, including cervical cancer, breast cancer, prostate cancer and lung cancer, among others. Over the past few decades, radiotherapy has witnessed a paradigm shift due to significant advancements in medical technologies. As the burden of cancer on the overall healthcare industry continues to grow, advent of new technologies and treatment techniques is expected to spur growth in the radiation therapy equipment market and also transform the manner in which cancer treatments are planned and the way in which doses are delivered. Advancing cancer treatment technologies, increased focus on accurate diagnosis, availability of precise treatment planning systems. and increasing availability of reimbursement coverage for radiotherapy treatments is expected to favor market growth. However, amidst the ongoing COVID-19 pandemic, there has been a decline in urgent referrals from general practitioners to cancer services for people suspected to having the disease and also a drop in chemotherapy appointments from cancer patients, thus impacting the market. The market is being favored by the steady pace of technological advancements being seen in radiotherapy devices and cancer research over the years, which is fueling their adoption among physicians worldwide. Reducing cost of treatment in several developed nations, and increasing government and private investments in research and development associated with cancer treatment are fostering growth in the global radiotherapy equipment market. The recent advancements and innovations in the radiation therapy space have led to the development of effective treatments, a good prognosis, and reduced side effects during the treatment.

Research Methodology
This latest edition of the research study is conducted and published by Global Industry Analysts, Inc., in close collaboration with senior executives in the industry driving strategy, business development, marketing, sales, product management, technology and operations. The views, opinions and findings presented are based on validated engagements from a total executive pool size of 732. Among this pool, 146 direct interactions with domain experts were carried out via our proprietary market research platform, MarketGlass. Among the 29 unique participations, a total of 13 validated responses were received as part of this report's primary research outreach program. We are unique in the industry to provide our clients with the validated list executive engagements and the complete project data stack.

Key Competitors Covered in the Report -
Hitachi America, Ltd.
Elekta AB
Varian Medical Systems, Inc.
Sumitomo Heavy Industries Ltd.
Brainlab AG
Accuray, Inc.
Nordion Inc.
RAYSEARCH Laboratories AB

Segments Covered in the Report -
Type (External Beam Radiation Therapy, Internal Radiation Therapy, Systemic Radiation Therapy)
End-Use (Hospitals, Other End-Uses)

Geographies Analyzed in the Report -
World
USA
Canada
Japan
China
Europe
France
Germany
Italy
UK
Spain
Russia
Rest of Europe
Asia-Pacific
Australia
India
South Korea
Rest of Asia-Pacific
Latin America
Argentina
Brazil
Mexico
Rest of Latin America
Middle East
Iran
Israel
Saudi Arabia
UAE
Rest of Middle East
Africa.

View Executive Engagement Dashboards, COVID Impact Questionnaires & Get Complimentary Access to Methodology & Full-Text Secondary Sources

For enquiries e-mail us at sales@strategyR.com .

For cutting edge analyst reviews on top industries, follow us on Twitter and connect with us on LinkedIn

About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) (www.strategyr.com) is the world`s only influencer driven AI powered market research company. Serving more than 41,000 clients from 36 countries, GIA is recognized for accurate forecasting of markets and industries for 33 years, offering the widest coverage of topics, geographic markets, competitive brands, and companies profiled.

Contact Us:
Zak Ali
Director, Corporate Communications
Global Industry Analysts, Inc.
Phone: 1-408-528-9966
Email: sales@StrategyR.com